Eisai Transfers Medical Device Subsidiary To Terumo
This article was originally published in PharmAsia News
Executive Summary
Eisai announced June 19 that the company signed an agreement with Terumo to transfer all shares of Clinical Supply, a Eisai subsidiary that manufactures and markets medical devices such as catheters. Within 30 days, Eisai will transfer 84.8 percent of Clinical Supply shares to Terumo, which is strengthening its catheter business. No details on the deal's price were disclosed. (Click here for more - Japanese language)
You may also be interested in...
Japan Device Maker Terumo To Boost Catheter Production In U.S., Europe, Vietnam
TOKYO - Seeing little growth prospect in Japan's rapidly aging population, leading medical device maker Terumo Corp. will boost its catheter production at plants in Maryland, Belgium, Vietnam and Japan as part of its new mid-term business plan, a company spokesman said July 4
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.